Debora Lanznaster
14PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Jan 21, 2023
Study of Ubiquitin Pathway Genes in a French Population with Amyotrophic Lateral Sclerosis: Focus on HECW1 Encoding the E3 Ligase NEDL1.Shanez Haouari, Christian Robert Andres, Debora Lanznaster
|Sep 23, 2022
Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases.Débora Lanznaster, Giulia Dingeo, Rayhanatou Altine Samey
|Jul 27, 2022
Taking Advantages of Blood-Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?Hugo Alarcan, Yara Al Ojaimi, Debora Lanznaster
|Jun 24, 2022
Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis.Débora Lanznaster, Clément Bruno, Jérôme Bourgeais
|Jun 02, 2022
TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target.Yara Al Ojaimi, Audrey Dangoumau, Hugo Alarcan
|Apr 12, 2022
The Roles of NEDD4 Subfamily of HECT E3 Ubiquitin Ligases in Neurodevelopment and Neurodegeneration.Shanez Haouari, Patrick Vourc'h, Médéric Jeanne
Pageof 3
Frequent Collaborators
3 joint publications
Charlotte Veyrat-Durebex
2 joint publications
Philippe Corcia
2 joint publications
Olivier Hérault
2 joint publications
Patrick Vourc'h
2 joint publications
Hélène Blasco
2 joint publications
Patrick Emond
1 joint publications
Theodora Bejan-Angoulvant
1 joint publications
Stephane Beltran
1 joint publications
Jean-Philippe Camdessanché
1 joint publications
Clément Bruno
